Xenon
DrugGroup A: xenon 60% (55%-65%)(1 MAC) in oxygen (FiO2 = 0.35-0.45)
Other names: LENOXe
NCT Number: NCT01199276
The objective of this study is to evaluate the incidence of Post-Operative Delirium (POD), diagnosed with the Confusion Assessment Method (CAM), in elderly patients undergoing hip fracture surgery under general anaesthesia with xenon or sevoflurane, for a period of four days post-surgery.
Looking for future studies?
Notify Me75 year and older
All sexes
Interventional
Phase 2
UZ Leuven, Leuven, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Group A: xenon 60% (55%-65%)(1 MAC) in oxygen (FiO2 = 0.35-0.45)
Other names: LENOXe
Group B: sevoflurane 1.1-1.4%(1 MAC) in oxygen (FiO2 = 0.35-0.45) and Medical air
Time frame: Four days
Time frame: About 7 days
Time frame: four days
Time frame: fifteen minutes
Time frame: up to thirty days
Time frame: Up to thirty days
Serious Adverse Events, Adverse Events, laboratory parameters
Air Liquide Santé International
Industry
An International, Multi-center, Randomized, Controlled Trial Evaluating The Effect of Xenon on Post-operative Delirium in Elderly Patients Undergoing Hip Fracture Surgery
Acronym: HIPELD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06504251
Confusion, Delirium
Bangkok, Bangkoknoi, Thailand
View Trial DetailsNCT05308290
Confusion, Delirium
Baltimore, Maryland, United States
View Trial DetailsNCT07121309
Confusion, Delirium
Suzhou, Jiangsu, China
View Trial DetailsNCT03776526
Confusion, Delirium
Hamilton, Ontario, Canada
View Trial Details